Viking Therapeutics(VKTX) - 2024 Q2 - Earnings Call Transcript

Stephanie Diaz I'll now turn the call over to Brian Lian for his initial comment. I'll summarize the highlights from these studies later in the call. During the second quarter, Viking also announced early results from a series of internally developed dual agonists of the amylin and calcitonin receptors at the 84th Scientific Sessions of the American Diabetes Association. These compounds demonstrated body weight reductions, decreased food intake, and improved metabolic profile in animal models. Stephanie Dia ...